Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.36 |
| ▸ | ADRA2A known ✓ | P08913 | 1/20 | 0.36 |
| ▸ | DRD2 known ✓ | P14416 | 1/20 | 0.36 |
| ▸ | ADRA2B known ✓ | P18089 | 1/20 | 0.36 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.36 |
| ▸ | DRD1 known ✓ | P21728 | 1/20 | 0.36 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C known ✓ | P28335 | 1/20 | 0.36 |
| ▸ | HRH1 known ✓ | P35367 | 1/20 | 0.36 |
| ▸ | PIK3CD known ✓ | O00329 | 1/20 | 0.34 |
| ▸ | PIK3CA known ✓ | P42336 | 1/20 | 0.34 |
| ▸ | PIK3CB known ✓ | P42338 | 1/20 | 0.34 |
| ▸ | PIK3CG known ✓ | P48736 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.38 |
| ▸ | BAZ2A | Q9UIF9 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 8/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL8687311 | 1.00 | HSD11B1 (0.38) | HSD11B1BAZ2AFAAHLMNANPSR1 | |
| Oxalic Acid SCHEMBL8689265 | 0.74 | ALDH1A1 (0.47) | HSD11B1MAPK1TDP1KDM4ESMN1; SMN2 | |
| Oxalic Acid SCHEMBL8689582 | 0.74 | HSD11B1 (0.44) | HSD11B1BAZ2AFAAHLMNAHTR6 | |
| Oxalic Acid SCHEMBL8687416 | 0.74 | FAAH (0.41) | HSD11B1BAZ2AFAAHHCRTR2CTSL | |
| SCHEMBL1480507 | 0.73 | KDM4E (0.50) | HSD11B1FAAHCTSLCTSBCTSS | |
| Oxalic Acid SCHEMBL8689744 | 0.71 | CACNA1B (0.42) | HSD11B1FAAHTDP1MAPT | |
| Fumaric Acid SCHEMBL9049836 | 0.71 | MAPK1 (0.44) | LMNANPSR1CHRM2CHRM4CHRM5 | |
| Fumaric Acid SCHEMBL8687316 | 0.71 | MAPK1 (0.44) | LMNANPSR1CHRM2CHRM4CHRM5 | |
| Fumaric Acid SCHEMBL27545929 | 0.69 | KDM4E (0.36) | KDM4ESMN1; SMN2MAPT | |
| SCHEMBL1475902 | 0.66 | CTSL (0.55) | HSD11B1FAAHCTSLCTSBCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5834499-A | TREATING GASTROINTESTINAL DISORDERS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1998-11-10 | — | — | US | disclosed |
| EP-0749966-A1 | 5-HT 3 RECEPTOR AGONIST, NOVEL THIAZOLE DERIVATIVE, AND INTERMEDIATE THEREFOR | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1996-12-27 | — | — | EP | disclosed |